MX9304975A - Una composicion en polvo para inhalacion y procedimiento para preparar la misma. - Google Patents

Una composicion en polvo para inhalacion y procedimiento para preparar la misma.

Info

Publication number
MX9304975A
MX9304975A MX9304975A MX9304975A MX9304975A MX 9304975 A MX9304975 A MX 9304975A MX 9304975 A MX9304975 A MX 9304975A MX 9304975 A MX9304975 A MX 9304975A MX 9304975 A MX9304975 A MX 9304975A
Authority
MX
Mexico
Prior art keywords
inhalation
powder composition
preparing
procedure
same
Prior art date
Application number
MX9304975A
Other languages
English (en)
Inventor
Gordon Thomas Simpkin
Anne-Marie Leighton
Roy Trunley
Original Assignee
Rhone Poulenc Rorer Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Ltd filed Critical Rhone Poulenc Rorer Ltd
Publication of MX9304975A publication Critical patent/MX9304975A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Otolaryngology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Una composición en polvo para inhalación que comprende por lo menos un fármaco microfino y un vehículo, en la que por lo menos una porción de dicho vehículo comprende un agente antiestático.
MX9304975A 1992-08-14 1993-08-16 Una composicion en polvo para inhalacion y procedimiento para preparar la misma. MX9304975A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9217312A GB2269992A (en) 1992-08-14 1992-08-14 Powder inhalation formulations

Publications (1)

Publication Number Publication Date
MX9304975A true MX9304975A (es) 1994-05-31

Family

ID=10720370

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304975A MX9304975A (es) 1992-08-14 1993-08-16 Una composicion en polvo para inhalacion y procedimiento para preparar la misma.

Country Status (16)

Country Link
US (1) US5908639A (es)
EP (1) EP0654991B1 (es)
JP (1) JP3787573B2 (es)
AT (1) ATE154237T1 (es)
AU (1) AU678379B2 (es)
CA (1) CA2142126C (es)
DE (1) DE69311556T2 (es)
DK (1) DK0654991T3 (es)
ES (1) ES2106362T3 (es)
GB (1) GB2269992A (es)
GR (1) GR3024468T3 (es)
IL (1) IL106665A (es)
MX (1) MX9304975A (es)
NZ (1) NZ254945A (es)
WO (1) WO1994004133A1 (es)
ZA (1) ZA935943B (es)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9501841D0 (en) * 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
US5612053A (en) 1995-04-07 1997-03-18 Edward Mendell Co., Inc. Controlled release insufflation carrier for medicaments
GB9515182D0 (en) 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
US6017963A (en) * 1995-11-14 2000-01-25 Euro-Celtique, S.A. Formulation for intranasal administration
US5874064A (en) * 1996-05-24 1999-02-23 Massachusetts Institute Of Technology Aerodynamically light particles for pulmonary drug delivery
US5871010A (en) * 1996-06-10 1999-02-16 Sarnoff Corporation Inhaler apparatus with modified surfaces for enhanced release of dry powders
FR2756739B1 (fr) * 1996-12-05 2000-04-28 Astra Ab Nouvelle formulation de budesonide
SE9700133D0 (sv) * 1997-01-20 1997-01-20 Astra Ab New formulation
JP2001514663A (ja) 1997-03-12 2001-09-11 エスモンド，ロバート ダブリュー． アルツハイマー病を処置または予防するための方法
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) * 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6191154B1 (en) 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US7022311B1 (en) 1999-10-12 2006-04-04 Kaken Pharmaceutical Co., Ltd. Powdery inhalational preparations and process for producing the same
DK1223915T3 (da) * 1999-10-29 2006-03-06 Nektar Therapeutics Törpulverpræparater med forbedret dispersivitet
WO2001056581A1 (fr) * 2000-02-04 2001-08-09 Kissei Pharmaceutical Co., Ltd. Preparation en poudre pour inhalation et inhalateur de poudre contenant cette preparation
ATE392885T1 (de) 2000-02-28 2008-05-15 Pharmakodex Ltd Verabreichungssystemen für oral anzuwendende arzneimittel
PE20011227A1 (es) 2000-04-17 2002-01-07 Chiesi Farma Spa Formulaciones farmaceuticas para inhaladores de polvo seco en la forma de aglomerados duros
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
EP1913939B1 (en) 2000-06-27 2017-05-31 Vectura Limited Formulations for use in inhaler devices
DE60131399T3 (de) * 2000-06-27 2019-11-14 Vectura Ltd. Herstellungsverfahren für partikel zur verwendung in einer arzneizusammensetzung
US8048451B2 (en) 2000-11-30 2011-11-01 Vectura Limited Pharmaceutical compositions for inhalation
ES2689704T3 (es) * 2000-11-30 2018-11-15 Vectura Limited Partículas para usar en una composición farmacéutica
WO2003020197A1 (en) 2001-09-05 2003-03-13 Vectura Limited Improvements in or relating to the delivery of oral drugs
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
AU2003209475A1 (en) 2002-03-07 2003-09-16 Vectura Limited Fast melt multiparticulate formulations for oral delivery
SI1494732T1 (sl) 2002-03-20 2008-08-31 Mannking Corp Inhalacijski aparat
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
CN1758930B (zh) 2003-03-27 2010-06-09 株式会社新日本科学 鼻腔用粉末药剂喷药装置
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
WO2006016530A1 (ja) 2004-08-10 2006-02-16 Translational Research, Ltd. 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
EP1786784B1 (en) 2004-08-20 2010-10-27 MannKind Corporation Catalysis of diketopiperazine synthesis
KR101306384B1 (ko) 2004-08-23 2013-09-09 맨카인드 코포레이션 약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염
EP1657278A1 (en) 2004-11-12 2006-05-17 SOLVAY (Société Anonyme) Coated particles of calcium carbonate having a high specific surface
AU2006290227B2 (en) 2005-09-14 2012-08-02 Mannkind Corporation Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents
US20070172430A1 (en) * 2006-01-20 2007-07-26 Nastech Pharmaceutical Company Inc. Dry powder compositions for rna influenza therapeutics
RU2403059C2 (ru) 2006-02-22 2010-11-10 Маннкайнд Корпорейшн Способ улучшения фармацевтических свойств микрочастиц, содержащих дикетопиперазин и активный агент
JP5415769B2 (ja) 2006-12-26 2014-02-12 株式会社新日本科学 経鼻投与用製剤
KR101629154B1 (ko) 2008-06-13 2016-06-21 맨카인드 코포레이션 건조 분말 흡입기 및 약물 투여 시스템
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2300083T3 (da) 2008-06-20 2013-07-22 Mannkind Corp Interaktivt apparat og fremgangsmåde til realtids-profilering af inhalationsforsøg
BRPI0915783A2 (pt) * 2008-07-18 2018-05-22 Prosonix Ltd processo para aumentar a cristalinidade de pelo menos um material sólido, partícula, composição farmacêutica ou agroquímica , e, inalador
TWI614024B (zh) 2008-08-11 2018-02-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
EP2400950B1 (en) 2009-02-26 2019-05-22 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
MX2011009512A (es) 2009-03-11 2011-11-29 Mannkind Corp Aparato, sistema y metodo para medir la resistencia de un inhalador.
EP2429495A4 (en) 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd INTRANASAL PHARMACEUTICAL COMPOSITIONS WITH ENHANCED PHARMACOKINETICS
SG176738A1 (en) 2009-06-12 2012-01-30 Mannkind Corp Diketopiperazine microparticles with defined specific surface areas
US8827946B2 (en) 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
CA2778698A1 (en) 2009-11-03 2011-05-12 Mannkind Corporation An apparatus and method for simulating inhalation efforts
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
BR112012033060A2 (pt) 2010-06-21 2018-02-27 Mannkind Corp métodos de sistema de liberação de fármaco em pó seco
CN105667994B (zh) 2011-04-01 2018-04-06 曼金德公司 用于药物药盒的泡罩包装
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US9233159B2 (en) 2011-10-24 2016-01-12 Mannkind Corporation Methods and compositions for treating pain
SG10201605800UA (en) 2012-07-12 2016-09-29 Mannkind Corp Dry powder drug delivery system and methods
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
JP6523247B2 (ja) 2013-03-15 2019-05-29 マンカインド コーポレイション 微結晶性ジケトピペラジン粒子の製造方法および乾燥粉末組成物の製造方法
CN114848614A (zh) 2013-07-18 2022-08-05 曼金德公司 热稳定性干粉药物组合物和方法
CA2920488C (en) 2013-08-05 2022-04-26 Mannkind Corporation Insufflation apparatus and methods
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4581225A (en) * 1984-04-25 1986-04-08 Eli Lilly And Company Sustained release intranasal formulation and method of use thereof
US4916230A (en) * 1984-07-02 1990-04-10 Merck & Co., Inc. Process for preparing novel N-(acyloxy-alkoxy)carbonyl derivatives useful as bioreversible prodrug moieties for primary and secondary amine functions in drugs
JP2770970B2 (ja) * 1987-04-09 1998-07-02 フアイソンズ・ピーエルシー ペンタミジンを含有する医薬組成物
US5039699A (en) * 1989-03-27 1991-08-13 Lederle (Japan), Ltd. Anti-peptic ulcer agent
JPH05963A (ja) * 1990-04-13 1993-01-08 Toray Ind Inc ポリペプチド類組成物
GB9020544D0 (en) * 1990-09-20 1990-10-31 Sandoz Ltd Improvements in or relating to organic compounds
IE71647B1 (en) * 1991-01-28 1997-02-26 Rhone Poulenc Rorer Ltd Benzamide derivatives

Also Published As

Publication number Publication date
ATE154237T1 (de) 1997-06-15
EP0654991B1 (en) 1997-06-11
CA2142126A1 (en) 1994-03-03
AU678379B2 (en) 1997-05-29
IL106665A (en) 1998-02-22
AU4725693A (en) 1994-03-15
GB9217312D0 (en) 1992-09-30
US5908639A (en) 1999-06-01
ES2106362T3 (es) 1997-11-01
EP0654991A1 (en) 1995-05-31
NZ254945A (en) 1996-06-25
WO1994004133A1 (en) 1994-03-03
IL106665A0 (en) 1993-12-08
DE69311556D1 (de) 1997-07-17
GR3024468T3 (en) 1997-11-28
JPH08500109A (ja) 1996-01-09
DK0654991T3 (da) 1997-12-29
DE69311556T2 (de) 1997-12-04
ZA935943B (en) 1994-06-09
CA2142126C (en) 2007-01-09
JP3787573B2 (ja) 2006-06-21
GB2269992A (en) 1994-03-02

Similar Documents

Publication Publication Date Title
MX9304975A (es) Una composicion en polvo para inhalacion y procedimiento para preparar la misma.
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
DE69417232T2 (de) Intravaginales wirkstoffabgabesystem
CA2163003A1 (en) Solubilizer and external preparations containing the same
FI954098A0 (fi) Kuivajauheen inhalaattorin lääkeaineen kantolaite
NO911260D0 (no) Utleveringssystem for aromastoff og soetningsmiddel, samt fremgangsmaate for fremstilling av et slikt system.
EP0995434A3 (en) Medicinal aerosol formulations
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
YU50695A (sh) Obložena pesticidna sredstva, postupci za njihovo dobijanje i smese koje ih sadrže
NZ238552A (en) Benzodiazepin-2-amine derivatives; preparatory processes, use, and medicaments
HU904007D0 (en) Medical preparations providing regulated active agent discharge and processes for the preparation thereof
ATE158172T1 (de) Pulverförmige pharmazeutische zusammensetzung
ES2131482A1 (es) Formulacion acuosa de bambuterol.
ES2013025A6 (es) Un metodo para preparar 24r-escimnol.
NO985079L (no) Eksplosiv formulering
AU7467994A (en) Novel polysaccharide and radioprotective agent containing the same as active ingredient
ES2186909T3 (es) Agentes antipaludicos y antibabesiosis y composiciones farmaceuticas que los contienen.
EP0419157A3 (en) Pharmacologically active compound., preparation and use
EP0360191A3 (en) Anti-aids virus composition
AU1119892A (en) Physiologically active kanglemycin c, process for preparing the same and use thereof
GB9217991D0 (en) New ethanolamine derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
IT8222494A0 (it) Derivati ad attivita'espettorante, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
MX19299A (es) 1,3-di-cicloalquilxantinas y procedimiento para supreparacion.
GB9028231D0 (en) Trifluoromethylketone derivatives,processes for preparation thereof and use thereof
IT8821137A0 (it) Fosfatidilcoline idrosolubili, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono.